Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business (Business Wire via Yahoo! Finance)
By Content Keyword RSS on Aug 11, 2008 in Health, Main Content
BRIDGEWATER, N.J.—-Enzon Pharmaceuticals, Inc. announced today that it is exploring strategic alternatives for its specialty pharmaceuticals business. These alternatives include, among other things, selling the entire specialty pharmaceuticals business, or selling one or more of Enzon’s marketed products, Oncaspar®, DepoCyt®, Abelcet® and Adagen®, and its Indianapolis, Indiana manufacturing …